BeStock  
Stocks › Biotechnology › RVMD

Revolution Medicines RVMD

US equityMarket cap rank #335Biotechnology
$210.61 +$5.35 (+2.60%)
Market open · Oct 1, 11:50 am ET · After hours $205.00 -0.13%
Open$204.00
Prev close$205.26
Day range$203.26 – $210.88
Volume633.2K
Market cap$45.14B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00
Operating profit-$505.13M-90.8% YoY
Net profit-$644.37M-160.1% YoY
Diluted EPS-$3.06-133.6% YoY
Free cash flow-$745.31M-225.2% YoY
Operating cash flow-$741.48M

Revenue, last 8 quarters

$0.0Sep '24$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26

Net profit, last 8 quarters

$-156.3MSep '24$-194.6MDec '24$-213.4MMar '25$-247.8MJun '25$-305.2MSep '25$-364.9MDec '25$-453.8MMar '26$-644.4MJun '26

Diluted EPS by quarter

-0.94Sep '24-1.12Dec '24-1.13Mar '25-1.31Jun '25-1.61Sep '25-1.86Dec '25-2.29Mar '26-3.06Jun '26

Free cash flow by quarter

$-133.9MSep '24$-139.5MDec '24$-197.7MMar '25$-229.2MJun '25$-210.7MSep '25$-276.2MDec '25$-355.7MMar '26$-745.3MJun '26

Annual revenue

$43.0MFY20$29.4MFY21$35.4MFY22$11.6MFY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-79.1%
Return on assets-52.4%
Return on invested capital-68.9%
Current ratio11.38
Liabilities / assets39.7%
Cash & investments$3.94B
Total debt$625.18M
Net cash (debt)$3.31B

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $505.13M $445.22M $1.18B $361.63M $315.27M
Selling and Admin Expenses $110.21M $101.25M $195.04M $66.68M $52.76M
-General & Admin Expense $110.21M $101.25M $195.04M $66.68M $52.76M
Research & Development $394.92M $343.97M $987.33M $294.94M $262.51M
Operating Profit -$505.13M -$445.22M -$1.18B -$361.63M -$315.27M
Net Non-Operating Interest Income (Expense) $11.80M $7.31M $66.46M $9.36M $10.66M
Non-Operating Interest Income $35.58M $19.51M $90.69M $21.29M $22.08M
Non-Operating Interest Expense $23.78M $12.20M $24.23M $11.94M $11.43M
Other Income (Expense) -$151.04M -$15.91M -$15.40M -$12.62M -$592,000.00
Gain on Sale of Security -$151.03M -$15.79M -$15.36M -$12.63M -$592,000.00
Other Non-Operating Income (Expenses) -$6,000.00 -$117,000.00 -$37,000.00 $5,000.00 –
Pretax Profit -$644.37M -$453.82M -$1.13B -$364.89M -$305.21M
Net Profit -$644.37M -$453.82M -$1.13B -$364.89M -$305.21M
Profit from Continuing Operations -$644.37M -$453.82M -$1.13B -$364.89M -$305.21M
Net Income to Parent Company -$644.37M -$453.82M -$1.13B -$364.89M -$305.21M
Net Income to Common Stockholders -$644.37M -$453.82M -$1.13B -$364.89M -$305.21M
Basic EPS -$3.06 -$2.29 -$5.95 -$1.86 -$1.61
Diluted EPS -$3.06 -$2.29 -$5.95 -$1.86 -$1.61
Total Revenue as Reported – – $0.00 $0.00 $0.00
Tax – – $0.00 – –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $4.32B $2.25B $2.35B $2.35B $2.25B
Total Current Assets $4.03B $1.97B $2.08B $2.08B $1.98B
Cash and Cash Equivalents & Short-Term Investments $3.94B $1.91B $2.03B $2.03B $1.93B
-Cash and Cash Equivalents $815.44M $440.94M $383.75M $383.75M $217.44M
-Short Term Investments $3.12B $1.47B $1.64B $1.64B $1.71B
Other Current Assets $90.37M $59.83M $49.36M $49.36M $45.98M
Total Non-Current Assets $294.93M $285.82M $279.47M $279.47M $274.43M
Net PPE $162.45M $161.37M $165.28M $165.28M $167.38M
-Gross PPE $195.29M $192.05M $193.79M $193.79M $194.39M
-Accumulated Depreciation -$32.84M -$30.68M -$28.51M -$28.51M -$27.01M
Non-Current Prepaid Assets $42.45M $34.71M $24.15M $24.15M $16.85M
Goodwill and Other Intangible Assets $70.41M $70.41M $70.41M $70.41M $70.48M
-Goodwill $14.61M $14.61M $14.61M $14.61M $14.61M
-Other Intangible Assets $55.80M $55.80M $55.80M $55.80M $55.87M
Other Non-Current Assets $19.62M $19.34M $19.64M $19.64M $19.73M
Total Liabilities $1.72B $753.82M $723.21M $723.21M $655.02M
Total Current Liabilities $354.06M $289.60M $290.42M $290.42M $245.62M
Payables $88.42M $80.54M $64.62M $64.62M $74.85M
-Accounts Payable $88.42M $80.54M $64.62M $64.62M $74.85M
Current Accrued Expenses $179.06M $165.93M $143.29M $143.29M $114.42M
Short-Term Debt and Capital Lease Obligation $16.75M $16.61M $16.47M $16.47M $16.33M
-Current Capital Lease Obligation $16.75M $16.61M $16.47M $16.47M $16.33M
Other Current Liabilities $5.15M $3.26M $7.86M $7.86M $8.24M
Total Non-Current Liabilities $1.36B $464.22M $432.79M $432.79M $409.39M
Long Term Debt and Capital Lease Obligation $625.18M $140.02M $142.23M $142.23M $142.14M
-Long Term Debt $487.43M – – – –
-Long Term Capital Lease Obligation $137.74M $140.02M $142.23M $142.23M $142.14M
Derivative Product Liabilities $185.25M $34.33M $18.55M $18.55M $5.92M
Non-Current Deferred Liabilities $2.35M $2.35M $2.35M $2.35M $2.35M
Other Non-Current Liabilities $550.19M $287.52M $269.65M $269.65M $258.99M
Total Equity $2.61B $1.50B $1.63B $1.63B $1.60B
Stockholders' Equity $2.61B $1.50B $1.63B $1.63B $1.60B
Capital Stock $21,000.00 $19,000.00 $19,000.00 $19,000.00 $18,000.00
-Common Stock $21,000.00 $19,000.00 $19,000.00 $19,000.00 $18,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $6.58B $4.82B $4.50B $4.50B $4.10B
Retained Earnings -$3.97B -$3.32B -$2.87B -$2.87B -$2.50B
Gains/Losses Not Affecting Retained Earnings -$5.95M -$622,000.00 $3.24M $3.24M $3.12M

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$741.48M -$354.17M -$897.74M -$274.24M -$207.31M
Net cash flow from continuing operations -$741.48M -$354.17M -$897.74M -$274.24M -$207.31M
Net Income from Continuing Operations -$1.10B -$453.82M -$1.13B -$364.89M -$305.21M
Gain/Loss from Continuing Operations $166.82M $15.79M $15.39M $12.63M $624,000.00
Depreciation & Depletion & Amortization $9.04M $4.54M $16.56M $4.70M $4.34M
Other Non-Cash Items $35.10M $12.20M $24.23M $11.94M $11.43M
Change in Working Capital -$1.87M -$16.95M $86.82M $32.25M $56.44M
-Change in Prepaid Assets -$59.03M -$10.09M -$21.69M -$10.67M $6.43M
-Change in Payables and Accrued Expense $60.93M $118,000.00 $121.80M $44.10M $64.84M
-Change in Other Current Liabilities -$3.77M $3.59M -$420,000.00 -$1.03M -$2.11M
Net cash flow from investing -$1.49B $172.62M $118.06M $74.88M $24.85M
Net Cash Flow from Continuing Investing Activities -$1.49B $172.62M $118.06M $74.88M $24.85M
Net PPE Purchase and Sale -$3.82M -$1.54M -$15.99M -$1.93M -$3.35M
Net Investment Purchase and Sale -$1.48B $174.15M $134.05M $76.81M $28.20M
Financing Cash Flow $2.66B $238.74M $621.52M $365.66M -$1.59M
Net Cash Flow from Continuing Financing Activities $2.66B $238.74M $621.52M $365.66M -$1.59M
Net Issuance Payments Of Debt $487.07M – – – –
Net Common Stock Issuance $1.88B $226.73M $347.92M $347.92M $0.00
Proceeds from Stock Option Exercised $49.82M $12.27M $273.39M $261.77M $4.15M
Net Other Financing Charges $244.26M -$252,000.00 $220,000.00 -$244.02M -$5.74M
Ending Cash Balance $820.29M $445.80M $388.60M $388.60M $222.30M
Net Change in Cash $431.69M $57.19M -$158.16M $166.30M -$184.05M
Beginning Cash Balance $388.60M $388.60M $546.76M $222.30M $406.35M
Free Cash Flow -$745.31M -$355.70M -$913.73M -$276.16M -$210.66M
-Change in Other Current Assets – -$10.56M -$12.87M -$154,000.00 –
-Change in Receivables – – $0.00 $0.00 –

Discussion

No comments yet — be the first to weigh in on RVMD.

Leave a comment

Scroll to Top